Home
Mercati
Grafici & Idee
Algo
Notizie
Store
Broker
Scarica
Calendario Economico
Segnali di Trading
Terminale Web
Digita
/
per cercare: @user, $symbol
Cerca
Accedi
Crea un account
Italiano
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Türkçe
PHAT
#2142
Phathom Pharmaceuticals, Inc. Common Stock
12.5
6
-5.92%
Settore:
Base:
Valuta di Profitto:
Intervallo Giornaliero
Intervallo Annuale
Variazione giornaliera
-5.92%
Variazione Mensile
-11.42%
Variazione di 6 mesi
+1.05%
Variazione Annuale
+119.20%
Chiusura Precedente
13.3
5
Open
12.5
6
Bid
Ask
Low
12.5
6
High
12.5
6
Volume
149
Mercati
Mercato Azionario Statunitense
Salute
PHAT
Open full chart
Financials
Overview
Estratto Conto
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
31.32 M
31.71 M
41.97 M
58.48 M
69.64 M
78.8 M
—
Valuation ratios
Enterprise value
753.01 M
440.53 M
347.87 M
154.84 M
268.19 M
1.18 B
2.64 B
Price to earnings ratio
—
—
-2.37
-2.33
-1.53
-5.48
-11.87
Price to sales ratio
—
—
—
689.62
9.28
—
—
Price to cash flow ratio
—
—
3.2
3.42
1.92
7.25
14.69
Price to book ratio
—
—
6.27
6.46
2.02
2.76
4.31
Enterprise value to EBITDA ratio
—
—
—
-0.93
-0.97
—
—
Profitability ratios
Return on assets %
-0.44
-0.76
-1.2
-0.49
-0.88
0.85
-0.67
Return on equity %
-0.66
-1.99
-2.64
-2.77
-1.32
0.5
-0.49
Return on invested capital %
-2 378.1
-2 908.86
-12.39 K
-4 282.78
-3 385.5
1 189.71
—
Gross margin %
—
—
—
75.51
85.57
87.09
348.4
Operating margin %
—
—
—
-24.53 K
-502.18
91.36
-145.39
EBITDA margin %
—
—
—
-24.45 K
-500.75
-91
-467.77
Net margin %
—
—
—
-29.56 K
-605.09
126.35
-546.44
Liquidity ratios
Quick ratio
—
—
—
10.22
4.16
1.69
9.77
Current ratio
5.25
9.86
6.12
10.25
4.2
1.73
9.93
Inventory turnover
—
—
—
—
0.38
0.06
0.14
Asset turnover
—
—
—
0
0.14
0.55
0.66
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
0.13
0.47
0.58
0.33
0.53
0.81
3.18
Long term debt to total equity ratio
0.2
1.24
1.27
1.89
0.79
0.48
2.07
Per share metrics
Operating cash flow per share
—
—
3.75
2.68
4.22
2.29
2.31
EBIT per share
—
—
—
-3.26
-4.39
-2.19
-2.21
EBITDA per share
—
—
—
-3.25
-4.38
-2.19
-2.2
Total debt per share
—
—
—
—
—
—
—
Cash per share
—
—
3.97
7.44
4.71
1.78
8.64
Net current asset value per share
—
—
4.1
7.75
5.7
3.14
12.67
Tangible book value per share
—
—
1.91
1.42
4.01
6.01
22.07
Working capital per share
—
—
3.43
6.99
4.34
1.33
7.3
Book value per share
—
—
1.91
1.42
4.01
6.01
22.07
Notizie
Guggenheim alza il target su Phathom a $25 dopo ricavi record
Phathom Pharmaceuticals, Inc. (PHAT) Q4 2025 Earnings Call Transcript
Stifel conferma Buy su Phathom, mantiene target $28
Stifel reiterates Buy on Phathom stock, keeps $28 price target
Phathom Q4 2025: crescita dei ricavi del 217%, redditività in vista
Phathom Q4 2025 slides: 217% revenue growth, profitability in sight
Gli EPS di Phathom Pharma hanno battuto le aspettative per 0,34$, il fatturato supera le previsioni
Phathom Pharma earnings beat by $0.34, revenue topped estimates
Iovance Biotherapeutics (IOVA) Reports Q4 Loss, Tops Revenue Estimates
Phathom Pharmaceuticals mantiene rating Buy da Stifel grazie a solide prospettive di ricavi
Phathom Pharmaceuticals stock maintains Buy rating at Stifel on strong revenue outlook
Cantor Fitzgerald conferma rating Overweight su Phathom con target a $29